EP2812702
Diagnosis and management of CD30-expressing cancers
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.2.2013EP published:
17.4.2019EP application number:
13746038.2
EPO information:
European Patent Register
Max expiry date:
7.2.2033
Title:
Diagnosis and management of CD30-expressing cancers
Timeline
Today
8.2.2013EP application
17.4.2019EP Publication
Owner
Name:
Seattle Genetics, Inc.Address:
21823 30th Drive, S.E., 98021, Bothell, WA, US
Inventor
Name:
ALBERTSON, TinaAddress:
BothellWashington, US
Name:
SMITH, Maria, LAddress:
BothellWashington, US
Priority
Number:
201261597547 PDate:
10.2.2012Country:
US
Classification
Categories:
G01N 33/574, A61K 39/395